Aquestive Therapeutics director Richard J. Daly reports acquisition of $99,330.625 in common shares
AQST•Director Richard J. Daly purchased 28,025 Aquestive Therapeutics common shares for a total of $99,330.625, bringing his direct beneficial ownership to 28,025 shares.
1. Share purchases
Daly purchased 1,200 common shares at $3.53 each and another 26,825 shares at $3.545 each. The purchases brought his direct beneficial ownership to 28,025 common shares.
